Clinical Trials for Peritoneal Mesothelioma

Exclusive Content
Dr. Prakash Pandalai shares insights into clinical trials for peritoneal mesothelioma. He discusses the role of clinical research in studying treatment approaches and advancing care for people facing this rare cancer.
The clinical trials in peritoneal mesothelioma are rare because it's such a rare disease. But I'm really excited about trials that are being done in Europe right now using dendritic cells and different vaccines to perhaps stimulate the immune response after cytoreductive surgery and HIPEC in order to prevent recurrences, as well as the use of immunotherapy after cytoreductive surgery and heated intraperitoneal chemotherapy.
Explore Videos Topics